🇺🇸 FDA
Patent

US 11453861

Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

granted A61KA61K2039/804A61K2239/31

Quick answer

US patent 11453861 (Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)) held by Precision BioSciences, Inc. expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Precision BioSciences, Inc.
Grant date
Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/804, A61K2239/31, A61K2239/38, A61K2239/48